Full metadata record

DC Field Value Language
dc.contributor.authorKim, Kwangmeyung-
dc.contributor.authorKim, Jong Ho-
dc.contributor.authorPark, Hyungkyu-
dc.contributor.authorKim, Yoo-Shin-
dc.contributor.authorPark, Kyeongsoon-
dc.contributor.authorNam, Heayun-
dc.contributor.authorLee, Seulki-
dc.contributor.authorPark, Jae Hyung-
dc.contributor.authorPark, Rang-Woon-
dc.contributor.authorKim, In-San-
dc.contributor.authorChoi, Kuiwon-
dc.contributor.authorKim, Sang Yoon-
dc.contributor.authorPark, Kinam-
dc.contributor.authorKwon, Ick Chan-
dc.date.accessioned2024-01-20T18:33:35Z-
dc.date.available2024-01-20T18:33:35Z-
dc.date.created2021-09-05-
dc.date.issued2010-09-01-
dc.identifier.issn0168-3659-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/131116-
dc.description.abstractTheragnostic multifunctional nanoparticles hold great promise in simultaneous diagnosis of disease, targeted drug delivery with minimal toxicity, and monitoring of treatment. One of the current challenges in cancer treatment is enhancing the tumor-specific targeting of both imaging probes and anticancer agents. Herein, we report tumor-homing chitosan-based nanoparticles (CNPs) that simultaneously execute cancer diagnosis and therapy (cancer theragnosis). These CNPs are unique for their three distinctive characteristics, such as stability in serum, deformability, and rapid uptake by tumor cells. These properties are critical in increasing their tumor targeting specificity and reducing their nonspecific uptake by normal tissues. To develop these CNPs into novel theragnostic nanoparticles, we labeled them with Cy5.5, a near-infrared fluorescent (NIRF) dye, for imaging and also loaded them with paclitaxel (PTX-CNPs), an anticancer drug, for cancer treatment. Cy5.5 labeled PTX-CNPs exhibited significantly increased tumor-homing ability with low nonspecific uptake by other tissues in SCC7 tumor-bearing mice. Theragnostic nanoparticles, Cy5.5 labeled PTX-CNPs, are highly useful for simultaneous diagnosis of early-stage cancer and drug delivery. (C) 2010 Elsevier B.V. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER SCIENCE BV-
dc.subjectGLYCOL CHITOSAN NANOPARTICLES-
dc.subjectSELF-ASSEMBLED NANOPARTICLES-
dc.subjectANTITUMOR EFFICACY-
dc.subjectDOXORUBICIN-
dc.subjectPACLITAXEL-
dc.subjectBIODISTRIBUTION-
dc.subjectMECHANISM-
dc.subjectCARRIERS-
dc.titleTumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring-
dc.typeArticle-
dc.identifier.doi10.1016/j.jconrel.2010.04.004-
dc.description.journalClass1-
dc.identifier.bibliographicCitationJOURNAL OF CONTROLLED RELEASE, v.146, no.2, pp.219 - 227-
dc.citation.titleJOURNAL OF CONTROLLED RELEASE-
dc.citation.volume146-
dc.citation.number2-
dc.citation.startPage219-
dc.citation.endPage227-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000281261900009-
dc.identifier.scopusid2-s2.0-77955417363-
dc.relation.journalWebOfScienceCategoryChemistry, Multidisciplinary-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle; Proceedings Paper-
dc.subject.keywordPlusGLYCOL CHITOSAN NANOPARTICLES-
dc.subject.keywordPlusSELF-ASSEMBLED NANOPARTICLES-
dc.subject.keywordPlusANTITUMOR EFFICACY-
dc.subject.keywordPlusDOXORUBICIN-
dc.subject.keywordPlusPACLITAXEL-
dc.subject.keywordPlusBIODISTRIBUTION-
dc.subject.keywordPlusMECHANISM-
dc.subject.keywordPlusCARRIERS-
dc.subject.keywordAuthorTheragnosis-
dc.subject.keywordAuthorChitosan nanoparticle-
dc.subject.keywordAuthorPaclitaxel-
dc.subject.keywordAuthorTumor homing-
dc.subject.keywordAuthorDrug delivery-
dc.subject.keywordAuthorNon-invasive imaging-
Appears in Collections:
KIST Article > 2010
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE